HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Elaine E. Tseng Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Azadani, A. N. Articles by Tseng, E. E. Search for Related Content PubMed PubMed Citation Articles by Azadani, A. N. Articles by Tseng, E. E. Related Collections Valve disease

---

Original Articles: Adult Cardiac

Energy Loss Due to Paravalvular Leak With Transcatheter Aortic Valve Implantation

^a Department of Surgery, University of California at San Francisco Medical Center, San Francisco, California
^b San Francisco Veterans Affairs Medical Center, San Francisco, California

Accepted for publication August 11, 2009.

^_* Address correspondence to Dr Tseng, Division of Cardiothoracic Surgery, UCSF Medical Center, 500 Parnassus Ave., Suite 405W, Box 0118, San Francisco, CA 94143-0118 (Email: elaine.tseng{at}ucsfmedctr.org).

Background: Mild to moderate paravalvular leaks commonly occur after transcatheter aortic valve (TAV) implantation. Current TAVs match and may exceed hemodynamic performance of surgically implanted bioprostheses based on pressure gradient and effective orifice area. However, these hemodynamic criteria do not account for paravalvular leaks. We recently demonstrated that TAV implantation within 23 mm Perimount bioprostheses (Edwards Lifesciences, Irvine, CA) yields similar hemodynamics to the 23 mm Perimount valve. However, mild paravalvular leakage was seen after TAV implantation. The present study quantifies energy loss during the entire cardiac cycle to assess the impact of TAV paravalvular leaks on the ventricle.

Methods: Four TAVs designed to mimic the 23 mm SAPIEN valve (Edwards Lifesciences) were created. Transvalvular energy loss of 19, 21, and 23 mm Carpentier-Edwards bioprostheses were obtained in vitro within a pulse duplicator as a hemodynamic baseline (n = 4). The 23 mm TAVs were subsequently implanted within the 23 mm bioprostheses to assess energy loss due to paravalvular leak.

Results: The 23 mm bioprosthesis demonstrated the least energy loss (213.25 ± 31.35 mJ) compared with the 19 mm (330.00 ± 36.97 mJ, p = 0.003) and 21 mm bioprostheses (298.00 ± 37.25 mJ, p = 0.008). The TAV controls had similar energy loss (241.00 ± 30.55 mJ, p = 0.17) as the 23 mm bioprostheses. However, after TAV implantation, total energy loss increased to 365.33 ± 8.02 mJ significantly exceeding the energy loss of the 23 mm bioprosthesis (p < 0.001). Due to mild TAV paravalvular leakage, 39% of energy loss occurred during diastole.

Conclusions: Substantial energy loss during diastole occurs due to TAV paravalvular leakage. In the presence of mild paravalvular leakage, TAV implantation imposes a significantly higher workload on the left ventricle than an equivalently sized surgically implanted bioprosthesis.

This article has been cited by other articles:

				A. N. Azadani and E. E. Tseng Transcatheter Heart Valves for Failing Bioprostheses: State-of-the-Art Review of Valve-in-Valve Implantation Circ Cardiovasc Interv, December 1, 2011; 4(6): 621 - 628. [Full Text] [PDF]

				A. N. Azadani, N. Jaussaud, L. Ge, S. Chitsaz, T. A. M. Chuter, and E. E. Tseng Valve-in-Valve Hemodynamics of 20-mm Transcatheter Aortic Valves in Small Bioprostheses Ann. Thorac. Surg., August 1, 2011; 92(2): 548 - 555. [Abstract] [Full Text] [PDF]

				M. Abdel-Wahab, R. Zahn, M. Horack, U. Gerckens, G. Schuler, H. Sievert, H. Eggebrecht, J. Senges, G. Richardt, and for the German transcatheter aortic valve interven Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry Heart, June 1, 2011; 97(11): 899 - 906. [Abstract] [Full Text] [PDF]

				D. Silva, J.-H. Stripling, L. Hansen, and F.-C. Riess Aortic Valve Replacement After Transapical Valve-in-Valve Implantation Ann. Thorac. Surg., January 1, 2011; 91(1): e5 - e7. [Abstract] [Full Text] [PDF]

				M. A. Sherif, M. Abdel-Wahab, B. Stocker, V. Geist, D. Richardt, R. Tolg, and G. Richardt Anatomic and Procedural Predictors of Paravalvular Aortic Regurgitation After Implantation of the Medtronic CoreValve Bioprosthesis J. Am. Coll. Cardiol., November 9, 2010; 56(20): 1623 - 1629. [Abstract] [Full Text] [PDF]

				A. N. Azadani, N. Jaussaud, P. B. Matthews, L. Ge, T. A. M. Chuter, and E. E. Tseng Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses Interact CardioVasc Thorac Surg, July 1, 2010; 11(1): 70 - 77. [Abstract] [Full Text] [PDF]